Published in

Royal Society of Chemistry, Biomaterials Science, 9(9), p. 3228-3243, 2021

DOI: 10.1039/d1bm00137j

Links

Tools

Export citation

Search in Google Scholar

Immunomodulatory nanomedicine for colorectal cancer treatment: a landscape to be explored?

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Immunomodulatory nanomedicine has the potential to modulate CRC tumors with distinct associated immune cells, leading to the recruitment and activation of the immune populations, which will further, recognize tumor cells and allow its elimination.